These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19358949)

  • 1. The year in atherothrombosis.
    Sanz J; Moreno PR; Fuster V
    J Am Coll Cardiol; 2009 Apr; 53(15):1326-37. PubMed ID: 19358949
    [No Abstract]   [Full Text] [Related]  

  • 2. The year in atherothrombosis.
    Sanz J; Moreno PR; Fuster V
    J Am Coll Cardiol; 2013 Sep; 62(13):1131-43. PubMed ID: 23916939
    [No Abstract]   [Full Text] [Related]  

  • 3. Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology.
    Wickline SA; Neubauer AM; Winter P; Caruthers S; Lanza G
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):435-41. PubMed ID: 16373609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pan-cardiovascular syndrome - venous thromboembolism and atherothrombotic vascular disease.
    Weiss N
    Vasa; 2010 Aug; 39(3):207-11. PubMed ID: 20845579
    [No Abstract]   [Full Text] [Related]  

  • 5. Human genetics of atherothrombotic disease and its risk factors.
    Rader DJ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):741-7. PubMed ID: 25810293
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular risk factors in patients at high risk of atherothrombosis: what can be learned from registries?
    Goto S
    Thromb Haemost; 2008 Oct; 100(4):611-3. PubMed ID: 18841282
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atheroma: epidemiology and pathophysiology. The polyatheromatous patient].
    Griffon C; Cohen C; Stephan D
    Rev Prat; 2007 Apr; 57(7):797-803. PubMed ID: 17626327
    [No Abstract]   [Full Text] [Related]  

  • 8. The year in atherothrombosis.
    Sanz J; Moreno PR; Fuster V
    J Am Coll Cardiol; 2007 Apr; 49(16):1740-9. PubMed ID: 17448377
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone survey.
    Maniadakis N; Kourlaba G; Fragoulakis V
    BMC Cardiovasc Disord; 2011 Apr; 11():16. PubMed ID: 21492471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The year in atherothrombosis.
    Sanz J; Moreno PR; Fuster V
    J Am Coll Cardiol; 2010 Apr; 55(14):1487-98. PubMed ID: 20359599
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of risk of thrombosis in pregnant women].
    Shahbazov S; Kafarov I
    Georgian Med News; 2008 Oct; (163):12-7. PubMed ID: 18997246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The year in atherothrombosis.
    Sanz J; Moreno PR; Fuster V
    J Am Coll Cardiol; 2008 Mar; 51(9):944-55. PubMed ID: 18308164
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study.
    Kannel WB; Wolf PA
    Curr Atheroscler Rep; 2006 Jul; 8(4):317-23. PubMed ID: 16822398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
    Antoniades C; Bakogiannis C; Tousoulis D; Antonopoulos AS; Stefanadis C
    J Am Coll Cardiol; 2009 Aug; 54(8):669-77. PubMed ID: 19679244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal risk prevalence in sickle cell hemoglobinopathy.
    Abo-Zenah H; Moharram M; El Nahas AM
    Nephron Clin Pract; 2009; 112(2):c98-c106. PubMed ID: 19390209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of peripheral artery disease and the role of antiplatelet therapy.
    Aronow H; Hiatt WR
    Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Office and out of office heart rate measurements: which clinical value?
    Palatini P; Parati G; Julius S
    J Hypertens; 2008 Aug; 26(8):1540-5. PubMed ID: 18622227
    [No Abstract]   [Full Text] [Related]  

  • 18. Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?
    Del Rincón I
    Arthritis Rheum; 2009 Oct; 61(10):1284-6. PubMed ID: 19790116
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
    Yakubov S
    Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.